Cloning and sequencing of human immunoglobulin V lambda gene segments

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Antibody fragments are crucial for therapeutic applications.
• Understanding the diversity of antibody genes is essential for designing effective therapeutics.
• Human antibody gene repertoire diversity influences immune response and drug development.

Purpose of the Study:

• To isolate and characterize human variable (V) gene segments of lambda light chains.
• To establish a comprehensive directory of human V lambda segments for synthetic antibody fragment generation.
• To assess the diversity of complementarity-determining regions (CDRs) within the human V lambda repertoire.

Main Methods:

• Polymerase chain reaction (PCR) was employed to amplify human V lambda gene segments.
• Primers were designed based on known human V lambda sequences.
• Sequence analysis and compilation were performed to identify novel segments and families.

Main Results:

• Fourteen new human V lambda segments, including four pseudogenes, were isolated from a single individual.
• A comprehensive directory of human V lambda segments with open reading frames was compiled.
• A new V lambda family, designated V lambda IX, was identified.
• Significant sequence variation was observed in the complementarity-determining regions (CDRs) of most V lambda segments (22/24).

Conclusions:

• The study provides essential building blocks for constructing synthetic antibody fragments.
• The identified V lambda segments and the new V lambda IX family expand the known human V lambda repertoire.
• The high diversity in CDRs suggests a broad structural diversity of antigen-binding sites within the human population.
• This genetic diversity is fundamental for the human immune system's ability to recognize a wide range of antigens.